Simon Michel, CEO and board member of the Ypsomed Group. With Ypsomed since 2006.

Simon Michel studied economics at the University of St. Gallen. He is a member of various boards of directors in the technology and research environment and a member of the board committee of economiesuisse and the umbrella organization for Swiss medical technology, Swiss Medtech. He was elected to the Cantonal Council of the Canton of Solothurn for the FDP in 2017, and to the National Council in 2023.

‍